Protalix Biotherapeutics Inc (PLX) — Cash Flow-to-Debt Ratio
Protalix Biotherapeutics Inc (PLX) has a Cash Flow-to-Debt Ratio of 0.06x as of December 2025, meaning its operating cash flow of $2.03 Million could theoretically repay 0% of its total liabilities ($34.12 Million) in one year. Explore Protalix Biotherapeutics Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Protalix Biotherapeutics Inc Cash Flow-to-Debt Ratio (1996–2025)
Historical debt coverage capacity for Protalix Biotherapeutics Inc across 30 annual periods. Also explore Protalix Biotherapeutics Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Protalix Biotherapeutics Inc (1996–2025)
Year-by-year debt coverage analysis for Protalix Biotherapeutics Inc. For market capitalisation and broader financial context, see PLX stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.35x | $-11.99 Million | $34.12 Million | ▼ -222.4% |
| 2024 | 0.29x | $8.67 Million | $30.21 Million | ▲ +1208.2% |
| 2023 | -0.03x | $-1.32 Million | $50.87 Million | ▲ +93.1% |
| 2022 | -0.38x | $-25.00 Million | $66.43 Million | ▼ -191.6% |
| 2021 | -0.13x | $-10.29 Million | $79.70 Million | ▲ +53.1% |
| 2020 | -0.27x | $-26.11 Million | $94.97 Million | ▼ -64.3% |
| 2019 | -0.17x | $-19.36 Million | $115.71 Million | ▼ -146.4% |
| 2018 | -0.07x | $-7.74 Million | $114.01 Million | ▲ +29.7% |
| 2017 | -0.10x | $-9.99 Million | $103.51 Million | ▲ +72.3% |
| 2016 | -0.35x | $-32.10 Million | $92.20 Million | ▼ -23.8% |
| 2015 | -0.28x | $-24.28 Million | $86.38 Million | ▼ -28.7% |
| 2014 | -0.22x | $-29.28 Million | $134.07 Million | ▲ +0.1% |
| 2013 | -0.22x | $-30.65 Million | $140.28 Million | ▼ -2924.7% |
| 2012 | 0.01x | $635.00K | $82.08 Million | ▲ +102.6% |
| 2011 | -0.30x | $-23.57 Million | $77.88 Million | ▲ +40.2% |
| 2010 | -0.51x | $-38.46 Million | $76.05 Million | ▼ -194.2% |
| 2009 | 0.54x | $44.45 Million | $82.79 Million | ▲ +121.7% |
| 2008 | -2.48x | $-16.02 Million | $6.46 Million | ▼ -5.6% |
| 2007 | -2.35x | $-10.45 Million | $4.45 Million | ▼ -24.7% |
| 2006 | -1.88x | $-5.09 Million | $2.70 Million | ▼ -89.5% |
| 2005 | -0.99x | $-72.47K | $72.93K | ▲ +58.3% |
| 2004 | -2.39x | $-168.12K | $70.47K | ▼ -37.6% |
| 2003 | -1.73x | $-136.68K | $78.82K | ▲ +6.5% |
| 2002 | -1.85x | $-146.59K | $79.07K | ▲ +81.9% |
| 2001 | -10.22x | $-789.43K | $77.28K | ▼ -10683.7% |
| 2000 | -0.09x | $-53.11K | $560.61K | ▲ +96.9% |
| 1999 | -3.07x | $-1.41 Million | $459.36K | ▼ -378.0% |
| 1998 | -0.64x | $-909.52K | $1.42 Million | ▼ -1831.8% |
| 1997 | -0.03x | $-247.92K | $7.47 Million | ▼ -500.7% |
| 1996 | -0.01x | $-40.57K | $7.34 Million | — |